Susquehanna International Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.05M Sell
62,600
-58,700
-48% -$4.14M ﹤0.01% 4633
2025
Q4
$8.16M Sell
121,300
-149,900
-55% -$10.1M ﹤0.01% 3318
2025
Q3
$19.9M Buy
271,200
+136,800
+102% +$9.09M ﹤0.01% 2215
2025
Q2
$6.99M Buy
134,400
+109,900
+449% +$6.25M ﹤0.01% 3374
2025
Q1
$1.56M Sell
24,500
-79,800
-77% -$4.64M ﹤0.01% 6112
2024
Q4
$4.99M Buy
104,300
+25,500
+32% +$1.31M ﹤0.01% 3595
2024
Q3
$4.51M Buy
78,800
+32,600
+71% +$1.87M ﹤0.01% 3764
2024
Q2
$2.42M Sell
46,200
-500
-1% -$21.9K ﹤0.01% 4719
2024
Q1
$1.9M Sell
46,700
-1,900
-4% -$71.2K ﹤0.01% 5464
2023
Q4
$1.8M Buy
48,600
+14,500
+43% +$546K ﹤0.01% 5595
2023
Q3
$1.3M Sell
34,100
-59,500
-64% -$2.44M ﹤0.01% 6036
2023
Q2
$3.38M Buy
93,600
+45,600
+95% +$1.56M ﹤0.01% 4174
2023
Q1
$1.83M Buy
48,000
+12,800
+36% +$600K ﹤0.01% 5325
2022
Q4
$2M Sell
35,200
-9,300
-21% -$476K ﹤0.01% 4703
2022
Q3
$1.76M Buy
44,500
+4,400
+11% +$194K ﹤0.01% 5193
2022
Q2
$1.76M Buy
40,100
+8,700
+28% +$376K ﹤0.01% 5178
2022
Q1
$1.25M Sell
31,400
-34,000
-52% -$1.21M ﹤0.01% 6576
2021
Q4
$2.63M Sell
65,400
-28,000
-30% -$1.05M ﹤0.01% 4898
2021
Q3
$3.8M Sell
93,400
-39,600
-30% -$1.66M ﹤0.01% 4454
2021
Q2
$6.04M Buy
133,000
+77,600
+140% +$3.43M ﹤0.01% 3676
2021
Q1
$2.31M Sell
55,400
-3,000
-5% -$137K ﹤0.01% 5572
2020
Q4
$2.49M Sell
58,400
-5,400
-8% -$194K ﹤0.01% 4643
2020
Q3
$1.68M Sell
63,800
-11,700
-15% -$326K ﹤0.01% 4953
2020
Q2
$2.02M Buy
75,500
+100
+0.1% +$2.26K ﹤0.01% 4476
2020
Q1
$1.36M Buy
75,400
+33,300
+79% +$632K ﹤0.01% 4700
2019
Q4
$746K Sell
42,100
-7,600
-15% -$132K ﹤0.01% 6119
2019
Q3
$771K Buy
49,700
+5,100
+11% +$84K ﹤0.01% 6286
2019
Q2
$766K Sell
44,600
-44,900
-50% -$725K ﹤0.01% 6295
2019
Q1
$1.44M Sell
89,500
-29,800
-25% -$483K ﹤0.01% 4302
2018
Q4
$1.75M Buy
119,300
+38,000
+47% +$606K ﹤0.01% 3725
2018
Q3
$1.48M Sell
81,300
-55,700
-41% -$976K ﹤0.01% 4511
2018
Q2
$2.31M Buy
137,000
+14,900
+12% +$282K ﹤0.01% 3768
2018
Q1
$2.39M Sell
122,100
-1,100
-0.9% -$21.3K ﹤0.01% 3594
2017
Q4
$2.5M Sell
123,200
-15,100
-11% -$278K ﹤0.01% 3528
2017
Q3
$2.4M Buy
138,300
+35,600
+35% +$482K ﹤0.01% 3583
2017
Q2
$1.32M Sell
102,700
-19,500
-16% -$260K ﹤0.01% 4694
2017
Q1
$1.58M Sell
122,200
-85,000
-41% -$1.07M ﹤0.01% 4153
2016
Q4
$2.05M Sell
207,200
-74,900
-27% -$820K ﹤0.01% 4017
2016
Q3
$3.41M Buy
282,100
+79,700
+39% +$814K ﹤0.01% 2728
2016
Q2
$1.75M Buy
202,400
+28,800
+17% +$284K ﹤0.01% 3812
2016
Q1
$1.64M Sell
173,600
-334,800
-66% -$3.15M ﹤0.01% 4145
2015
Q4
$8.81M Buy
508,400
+171,300
+51% +$2.73M ﹤0.01% 1885
2015
Q3
$4.53M Buy
337,100
+113,500
+51% +$2.28M ﹤0.01% 2817
2015
Q2
$5.05M Buy
223,600
+115,200
+106% +$2.02M ﹤0.01% 2897
2015
Q1
$1.55M Sell
108,400
-128,200
-54% -$1.85M ﹤0.01% 4836
2014
Q4
$2.28M Sell
236,600
-29,100
-11% -$259K ﹤0.01% 4198
2014
Q3
$2.42M Sell
265,700
-8,100
-3% -$77.1K ﹤0.01% 4273
2014
Q2
$2.71M Sell
273,800
-209,700
-43% -$1.78M ﹤0.01% 4080
2014
Q1
$6.14M Buy
483,500
+40,800
+9% +$606K ﹤0.01% 2604
2013
Q4
$6.64M Buy
442,700
+183,900
+71% +$2.37M ﹤0.01% 2545
2013
Q3
$2.86M Buy
258,800
+53,900
+26% +$449K ﹤0.01% 3559
2013
Q2
$1.63M Buy
+204,900
New +$1.3M ﹤0.01% 4229

Other funds holding HALO

Susquehanna International Group's HALO Position: Q1 2026 in Review

Susquehanna International Group reduced its Halozyme (HALO) stake by 28% in Q1 2026, selling an estimated $1.21M and leaving 44,486 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #5351.

Susquehanna International Group first reported a position in HALO in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.4M in Q1 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Susquehanna International Group held 44,486 shares of Halozyme worth $2.88M as of Q1 2026.
  • Susquehanna International Group sold 17,220 Halozyme shares in Q1 2026, an estimated $1.21M.
  • Halozyme made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5351 holding.
  • Susquehanna International Group first reported a position in Halozyme in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Halozyme position peaked at $10.4M in Q1 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.